Cargando…
Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy
Combination chemotherapy is widely exploited for suppressing drug resistance and achieving synergistic anticancer efficacy in the clinic. In this paper, the nanostructured targeting methotrexate (MTX) plus pemetrexed (PMX) chitosan nanoparticles (CNPs) were developed by modifying methoxy polye (thyl...
Autores principales: | Chen, Juan, Yang, Xiaobing, Huang, Liuqing, Lai, Huixian, Gan, Chuanhai, Luo, Xuetao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263111/ https://www.ncbi.nlm.nih.gov/pubmed/30472899 http://dx.doi.org/10.1080/10717544.2018.1477856 |
Ejemplares similares
-
Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
por: Salmaso, Stefano, et al.
Publicado: (2013) -
Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications
por: Youssef, Ahmed Adel Ali, et al.
Publicado: (2022) -
Brush Conformation of Polyethylene Glycol Determines
the Stealth Effect of Nanocarriers in the Low Protein Adsorption Regime
por: Li, Mengyi, et al.
Publicado: (2021) -
Synergistic anticancer effects of nanocarrier loaded with berberine and miR-122
por: Li, Lei, et al.
Publicado: (2018) -
Drug-Loaded Lipid-Coated Hybrid Organic-Inorganic “Stealth” Nanoparticles for Cancer Therapy
por: Li, Xue, et al.
Publicado: (2020)